<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35915417</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1129-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>The journal of headache and pain</Title><ISOAbbreviation>J Headache Pain</ISOAbbreviation></Journal><ArticleTitle>Long COVID headache.</ArticleTitle><Pagination><StartPage>93</StartPage><MedlinePgn>93</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">93</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s10194-022-01450-8</ELocationID><Abstract><AbstractText>Headache is among the most frequent symptoms persisting or newly developing after coronavirus disease 2019 (COVID-19) as part of the so-called long COVID syndrome. The knowledge on long COVID headache is still limited, however growing evidence is defining the features of this novel condition, in particular regarding clinical characteristics, some pathophysiological mechanisms and first treatment recommendations. Long COVID headache can present in the form of worsening of a preexisting primary headache, or, more specifically, in the form of a new (intermittent or daily) headache starting during the acute infection or after a delay. It often presents together with other long COVID symptoms, most frequently with hyposmia. It can manifest with a migrainous or, more frequently, with a tension-type-like phenotype. Persistent activation of the immune system and trigeminovascular activation are thought to play a role. As there are virtually no treatment studies, treatment currently is largely guided by the existing guidelines for primary headaches with the corresponding phenotype. The present report, a collaborative work of the international group of the Junior Editorial Board of The Journal of Headache and Pain aims to summarize the most recent evidence about long COVID headache and suggests approaches to the diagnosis and treatment of this disorder.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tana</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center of Excellence On Headache, Geriatrics and COVID-19 Clinic, SS Annunziata Hospital of Chieti, 66100, Chieti, Italy. claudio.tana@asl2abruzzo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bentivegna</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Internal Medicine and Emergency Medicine, Sant' Andrea Hospital, Sapienza University, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Soo-Jin</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harriott</LastName><ForeName>Andrea M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Headache and Neuropathic Pain Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Azor&#xed;n</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Headache Unit, Department of Neurology, Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labastida-Ramirez</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Headache Group, Wolfson Center for Age Related Diseases, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ornello</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departement of Applied Clinical Sciences and Biotechnology, University of L'Aquila, L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raffaelli</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Charit&#xe9; Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beltr&#xe1;n</LastName><ForeName>Elo&#xed;sa Rubio</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Headache Group, Wolfson Center for Age Related Diseases, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruscheweyh</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Ludwig Maximilians University, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Migraine and Headache Society, Frankfurt, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychosomatic Medicine and Psychotherapy, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martelletti</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Internal Medicine and Emergency Medicine, Sant' Andrea Hospital, Sapienza University, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Headache Pain</MedlineTA><NlmUniqueID>100940562</NlmUniqueID><ISSNLinking>1129-2369</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008881" MajorTopicYN="Y">Migraine Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronavirus disease-19</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Headache</Keyword><Keyword MajorTopicYN="N">Migraine</Keyword><Keyword MajorTopicYN="N">Morbidity</Keyword><Keyword MajorTopicYN="N">Pain</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>1</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35915417</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pii">10.1186/s10194-022-01450-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Renda G, Ricci F, Spinoni EG, Grisafi L, D'Ardes D, Mennuni M, Tana C, Rognoni A, Bellan M, Sainaghi PP, Pirisi M, De Vecchi S, Gallina S, Pierdomenico SD, Cipollone F, Patti G. Predictors of mortality and cardiovascular outcome at 6 months after hospitalization for COVID-19. J Clin Med. 2022;11(3):729. doi: 10.3390/jcm11030729.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030729</ArticleId><ArticleId IdType="pmc">PMC8836381</ArticleId><ArticleId IdType="pubmed">35160182</ArticleId></ArticleIdList></Reference><Reference><Citation>Polverino F, Stern DA, Ruocco G, Balestro E, Bassetti M, Candelli M, Cirillo B, Contoli M, Corsico A, D'Amico F, D'Elia E, Falco G, Gasparini S, Guerra S, Harari S, Kraft M, Mennella L, Papi A, Parrella R, Pelosi P, Poletti V, Polverino M, Tana C, Terribile R, Woods JC, Di Marco F, Martinez FD, ItaliCO study group Comorbidities, cardiovascular therapies, and COVID-19 mortality: a Nationwide, Italian Observational Study (ItaliCO) Front Cardiovasc Med. 2020;7:585866. doi: 10.3389/fcvm.2020.585866.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.585866</ArticleId><ArticleId IdType="pmc">PMC7583635</ArticleId><ArticleId IdType="pubmed">33195473</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Ricci F, Coppola MG, Mantini C, Lauretani F, Campanozzi D, Renda G, Gallina S, Lugar&#xe1; M, Cipollone F, Giamberardino MA, Mucci L. Prognostic significance of chest imaging by LUS and CT in COVID-19 inpatients: The ECOVID Multicenter Study. Respiration. 2022;101(2):122&#x2013;131. doi: 10.1159/000518516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518516</ArticleId><ArticleId IdType="pmc">PMC8450833</ArticleId><ArticleId IdType="pubmed">34515247</ArticleId></ArticleIdList></Reference><Reference><Citation>Martelletti P, Bentivegna E, Spuntarelli V, Luciani M. Long-COVID headache. SN Compr Clin Med. 2021;3(8):1704&#x2013;1706. doi: 10.1007/s42399-021-00964-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-021-00964-7</ArticleId><ArticleId IdType="pmc">PMC8136258</ArticleId><ArticleId IdType="pubmed">34036244</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, O&#x2019;Hara ME, Akrami A, Perego E, Olliaro P, Needham DM. 2022 Long COVID: aiming for a consensus. Lancet Resp Published online May 4, 2022 10.1016/S2213-2600(22)00135-7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9067938</ArticleId><ArticleId IdType="pubmed">35525253</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention . Post-COVID conditions. 2021.</Citation></Reference><Reference><Citation>World Health Organization . Coronavirus disease (COVID-19): post COVID-19 condition. 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">37184163</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Service . long-term effect of coronavirus (long COVID) 2022.</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Cuadrado ML, Florencio LL. Defining Post-COVID symptoms (Post-Acute COVID, long COVID, persistent Post-COVID): an integrative classification. Int J Environ Res Public Health. 2021;18(5):2621. doi: 10.3390/ijerph18052621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Headache Classification Committee of the International Headache Society The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1&#x2013;211. doi: 10.1177/0333102417738202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102417738202</ArticleId><ArticleId IdType="pubmed">29368949</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus Disease (COVID-19) Report. See (https://covid19.who.int/). last checked 28 April 2022.</Citation></Reference><Reference><Citation>Martelletti P, Bentivegna E, Luciani M, Spuntarelli V. Headache as a prognostic factor for COVID-19. Time to re-evaluate. SN Compr Clin Med. 2020;2(12):2509&#x2013;2510. doi: 10.1007/s42399-020-00657-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00657-7</ArticleId><ArticleId IdType="pmc">PMC7690334</ArticleId><ArticleId IdType="pubmed">33263101</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullen MF, Skipper CP, Hullsiek KH, Bangdiwala AS, Pastick KA, Okafor EC, Lofgren SM, Rajasingham R, Engen NW, Galdys A, Williams DA, Abassi M, Boulware DR. Symptoms of COVID-19 outpatients in the United States. Open Forum Infect Dis. 2020;7(7):ofaa271. doi: 10.1093/ofid/ofaa271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa271</ArticleId><ArticleId IdType="pmc">PMC7337847</ArticleId><ArticleId IdType="pubmed">33117855</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, Haroon S, Price G, Davies EH, Nirantharakumar K, Sapey E, Calvert MJ, TLC Study Group Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio A, Brenner MJ, De Luca P, Albanese M, D'Ascanio L, Ralli M, Roccamatisi D, Cingolani C, Vitelli F, Camaioni A, Di Girolamo S, Bernitsas E. Olfactory dysfunction, headache, and mental clouding in adults with Long-COVID-19: what is the link between cognition and olfaction? A Cross-Sectional Study. Brain Sci. 2022;12(2):154. doi: 10.3390/brainsci12020154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12020154</ArticleId><ArticleId IdType="pmc">PMC8870047</ArticleId><ArticleId IdType="pubmed">35203918</ArticleId></ArticleIdList></Reference><Reference><Citation>Montenegro P, Moral I, Puy A, Cordero E, Chantada N, Cuixart L, et al. Prevalence of post COVID-19 condition in primary care: a cross sectional study. Int J Environ Res Public Health. 2022;19(3):1836. doi: 10.3390/ijerph19031836.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19031836</ArticleId><ArticleId IdType="pmc">PMC8834857</ArticleId><ArticleId IdType="pubmed">35162857</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Navarro-Santana M, G&#xf3;mez-Mayordomo V, Cuadrado ML, Garc&#xed;a-Azor&#xed;n D, Arendt-Nielsen L, et al. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: a meta-analysis of the current literature. Eur J Neurol. 2021;28(11):3820&#x2013;3825. doi: 10.1111/ene.15040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15040</ArticleId><ArticleId IdType="pmc">PMC8444899</ArticleId><ArticleId IdType="pubmed">34327787</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozen TD. Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: lessons from the 1890 Russian/Asiatic flu. Cephalalgia. 2020;40(13):1406&#x2013;1409. doi: 10.1177/0333102420965132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965132</ArticleId><ArticleId IdType="pmc">PMC7645599</ArticleId><ArticleId IdType="pubmed">33146034</ArticleId></ArticleIdList></Reference><Reference><Citation>Dono F, Consoli S, Evangelista G, D'Apolito M, Russo M, Carrarini C, et al. New daily persistent headache after SARS-CoV-2 infection: a report of two cases. Neurol Sci. 2021;42(10):3965&#x2013;3968. doi: 10.1007/s10072-021-05444-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05444-3</ArticleId><ArticleId IdType="pmc">PMC8280630</ArticleId><ArticleId IdType="pubmed">34264414</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez JT, Garc&#xed;a-Azor&#xed;n D, Planchuelo-G&#xf3;mez &#xc1;, Garc&#xed;a-Iglesias C, Due&#xf1;as-Guti&#xe9;rrez C, Guerrero &#xc1;L. Phenotypic characterization of acute headache attributed to SARS-CoV-2: an ICHD-3 validation study on 106 hospitalized patients. Cephalalgia. 2020;40(13):1432&#x2013;1442. doi: 10.1177/0333102420965146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965146</ArticleId><ArticleId IdType="pmc">PMC7645601</ArticleId><ArticleId IdType="pubmed">33146037</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacobucci G. Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show. BMJ. 2021;375:n3103. doi: 10.1136/bmj.n3103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n3103</ArticleId><ArticleId IdType="pubmed">34916215</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampaio Rocha-Filho PA, Voss L. Persistent headache and persistent anosmia associated with COVID-19. Headache. 2020;60(8):1797&#x2013;1799. doi: 10.1111/head.13941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13941</ArticleId><ArticleId IdType="pmc">PMC7436496</ArticleId><ArticleId IdType="pubmed">32790179</ArticleId></ArticleIdList></Reference><Reference><Citation>Uygun &#xd6;, Erta&#x15f; M, Ekizo&#x11f;lu E, Bolay H, &#xd6;zge A, Kocasoy Orhan E, &#xc7;a&#x11f;atay AA, Baykan B. Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain. 2020;21(1):121. doi: 10.1186/s10194-020-01188-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-020-01188-1</ArticleId><ArticleId IdType="pmc">PMC7552597</ArticleId><ArticleId IdType="pubmed">33050880</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Azorin D, Layos-Romero A, Porta-Etessam J, Membrilla JA, Caronna E, Gonzalez-Martinez A, Mencia &#xc1;S, Segura T, Gonzalez-Garc&#xed;a N, D&#xed;az-de-Ter&#xe1;n J, Gallardo VJ, Gago-Veiga AB, Ballv&#xe9; A, Trigo L&#xf3;pez J, Sastre-Real M, Llaurad&#xf3; A, Cornejo A, de Lorenzo &#xcd;, Guerrero-Peral &#xc1;, Pozo-Rosich P. Post-COVID-19 persistent headache: a multicentric 9-months follow-up study of 905 patients. Cephalagia. 2022;42(8):804&#x2013;809. doi: 10.1177/03331024211068074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211068074</ArticleId><ArticleId IdType="pubmed">35166156</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, G&#xf3;mez-Mayordomo V, Cuadrado ML, Palacios-Ce&#xf1;a D, Florencio LL, Guerrero AL, Garc&#xed;a-Azor&#xed;n D, Hern&#xe1;ndez-Barrera V, Arendt-Nielsen L. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: a case-control study. Cephalalgia. 2021;41(13):1332&#x2013;1341. doi: 10.1177/03331024211020404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211020404</ArticleId><ArticleId IdType="pmc">PMC8212025</ArticleId><ArticleId IdType="pubmed">34134526</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, G&#xf3;mez-Mayordomo V, Garc&#xed;a-Azor&#xed;n D, Palacios-Ce&#xf1;a D, Florencio LL, Guerrero AL, Hern&#xe1;ndez-Barrera V, Cuadrado ML. Previous history of migraine is associated with fatigue, but not headache, as long-term post-COVID symptom after severe acute respiratory SARS-CoV-2 infection: a Case-Control Study. Front Hum Neurosci. 2021;15:678472. doi: 10.3389/fnhum.2021.678472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2021.678472</ArticleId><ArticleId IdType="pmc">PMC8290894</ArticleId><ArticleId IdType="pubmed">34295230</ArticleId></ArticleIdList></Reference><Reference><Citation>Membrilla JA, de Lorenzo &#xcd;, Sastre M, D&#xed;az de Ter&#xe1;n J. Headache as a cardinal symptom of coronavirus disease 2019: a cross-sectional study. Headache. 2020;60(10):2176&#x2013;2191. doi: 10.1111/head.13967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13967</ArticleId><ArticleId IdType="pmc">PMC7646273</ArticleId><ArticleId IdType="pubmed">32989732</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Martinez A, Fanjul V, Ramos C, Serrano Ballesteros J, Bustamante M, Villa Mart&#xed; A, &#xc1;lvarez C, Garc&#xed;a Del &#xc1;lamo Y, Vivancos J, Gago-Veiga AB. Headache during SARS-CoV-2 infection as an early symptom associated with a more benign course of disease: a case-control study. Eur J Neurol. 2021;28(10):3426&#x2013;3436. doi: 10.1111/ene.14718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14718</ArticleId><ArticleId IdType="pubmed">33417287</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E, Ballv&#xe9; A, Llaurad&#xf3; A, Gallardo VJ, Ariton DM, Lallana S, L&#xf3;pez Maza S, Oliv&#xe9; Gadea M, Quibus L, Restrepo JL, Rodrigo-Gisbert M, Vilaseca A, Hernandez Gonzalez M, Martinez Gallo M, Alpuente A, Torres-Ferrus M, Pujol Borrell R, Alvarez-Sabin J, Pozo-Rosich P. Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020;40(13):1410&#x2013;1421. doi: 10.1177/0333102420965157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965157</ArticleId><ArticleId IdType="pmc">PMC7645597</ArticleId><ArticleId IdType="pubmed">33146036</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigo J, Garc&#xed;a-Azor&#xed;n D, Planchuelo-G&#xf3;mez &#xc1;, Mart&#xed;nez-P&#xed;as E, Talavera B, Hern&#xe1;ndez-P&#xe9;rez I, Valle-Pe&#xf1;acoba G, Sim&#xf3;n-Campo P, de Lera M, Chavarr&#xed;a-Miranda A, L&#xf3;pez-Sanz C, Guti&#xe9;rrez-S&#xe1;nchez M, Mart&#xed;nez-Velasco E, Pedraza M, Sierra &#xc1;, G&#xf3;mez-Vicente B, Arenillas JF, Guerrero &#xc1;L. Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study. J Headache Pain. 2020;21(1):94. doi: 10.1186/s10194-020-01165-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-020-01165-8</ArticleId><ArticleId IdType="pmc">PMC7388434</ArticleId><ArticleId IdType="pubmed">32727345</ArticleId></ArticleIdList></Reference><Reference><Citation>Karada&#x15f; &#xd6;, &#xd6;zt&#xfc;rk B, Sonkaya AR, Ta&#x15f;delen B, &#xd6;zge A, Bolay H. Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6. Neurol Sci. 2021;42(5):1665&#x2013;1673. doi: 10.1007/s10072-020-04978-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04978-2</ArticleId><ArticleId IdType="pmc">PMC7870778</ArticleId><ArticleId IdType="pubmed">33559789</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolay H, Karadas &#xd6;, Ozt&#xfc;rk B, Sonkaya R, Tasdelen B, Bulut TDS, G&#xfc;lbahar &#xd6;, &#xd6;zge A, Baykan B. HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism. J Headache Pain. 2021;22(1):94. doi: 10.1186/s10194-021-01306-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-021-01306-7</ArticleId><ArticleId IdType="pmc">PMC8358545</ArticleId><ArticleId IdType="pubmed">34384355</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigo J, Garc&#xed;a-Azor&#xed;n D, Sierra-Menc&#xed;a &#xc1;, Tamayo-Velasco &#xc1;, Mart&#xed;nez-Paz P, Tamayo E, Guerrero AL, Gonzalo-Benito H. Cytokine and interleukin profile in patients with headache and COVID-19: a pilot, CASE-control, study on 104 patients. J Headache Pain. 2021;22(1):51. doi: 10.1186/s10194-021-01268-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-021-01268-w</ArticleId><ArticleId IdType="pmc">PMC8177251</ArticleId><ArticleId IdType="pubmed">34088273</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Azor&#xed;n D, Gonzalez-Martinez A, Sierra Menc&#xed;a A, Trigo L&#xf3;pez J, Alberdi A, Blanco M, ICalcerrada I, Cornejo A, Cubero M, Gil A, Garc&#xed;a C, Lozano AG, Mart&#xed;nez Badillo C, Montilla C, Mora M, Nu&#xf1;ez G, Paniagua M, Perez C, Rojas M, Ruiz M, Sierra L, Hurtado L, Guerrero Peral AL. Clinical predictors of persistent post-COVID-19 headache. The International Headache Congress - IHS and EHF joint congress 2021 : Virtual. 8&#x2013;12 September 2021. J Headache Pain. 2021;22(Suppl 1):103.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Belvis R. Headaches during COVID-19: my clinical case and review of the literature. Headache. 2020;60(7):1422&#x2013;1426. doi: 10.1111/head.13841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13841</ArticleId><ArticleId IdType="pmc">PMC7273035</ArticleId><ArticleId IdType="pubmed">32413158</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparisi &#xc1;, Ybarra-Falc&#xf3;n C, Iglesias-Echeverr&#xed;a C, Garc&#xed;a-G&#xf3;mez M, Marcos-Mangas M, Valle-Pe&#xf1;acoba G, Carrasco-Moraleja M, Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Guerrero &#xc1;L, Garc&#xed;a-Azor&#xed;n D. Cardio-pulmonary dysfunction evaluation in patients with persistent Post-COVID-19 headache. Int J Environ Res Public Health. 2022;19(7):3961. doi: 10.3390/ijerph19073961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19073961</ArticleId><ArticleId IdType="pmc">PMC8997887</ArticleId><ArticleId IdType="pubmed">35409644</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, Lange F, Andersson JLR, Griffanti L, Duff E, Jbabdi S, Taschler B, Keating P, Winkler AM, Collins R, Matthews PM, Allen N, Miller KL, Nichols TE, Smith SM. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Planchuelo-G&#xf3;mez A, Garc&#xed;a-Azor&#xed;n D, Guerrero Peral AL, Aja-Fern&#xe1;ndez S, Rodr&#xed;guez M, Moro R, de Luis-Garc&#xed;a R. Gray matter cortical changes in patients with persistent headache after COVID-19 infection: an exploratory study. The International Headache Congress - IHS and EHF joint congress 2021 : Virtual. 8&#x2013;12 September 2021. J Headache Pain. 2021;22(Suppl 1):103.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Planchuelo-G&#xf3;mez A, Garc&#xed;a-Azor&#xed;n D, Guerrero Peral AL, Aja-Fern&#xe1;ndez S, Rodr&#xed;guez M, Moro R, de Luis-Garc&#xed;a R. White matter microstructural alterations in patients with persistent headache after COVID-19 infection: an exploratory study. The International Headache Congress - IHS and EHF joint congress 2021 : Virtual. 8&#x2013;12 September 2021. J Headache Pain. 2021;22(Suppl 1):103.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M, Morbelli S, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, Chiola S, Gelardi F, Chiti A. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging. 2021;48(10):3187&#x2013;3197. doi: 10.1007/s00259-021-05294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05294-3</ArticleId><ArticleId IdType="pmc">PMC7937050</ArticleId><ArticleId IdType="pubmed">33677642</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, Guis S, Barthelemy F, Habert P, Ceccaldi M, Million M, Raoult D, Cammilleri S, Eldin C. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48(9):2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiatkittikul P, Promteangtrong C, Kunawudhi A, Siripongsatian D, Siripongboonsitti T, Ruckpanich P, Thongdonpua S, Jantarato A, Piboonvorawong C, Fonghoi N, Chotipanich C. Abnormality pattern of F-18 FDG PET whole body with functional MRI brain in post-acute COVID-19. Nucl Med Mol Imaging. 2022;56(1):1&#x2013;13. doi: 10.1007/s13139-021-00730-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13139-021-00730-6</ArticleId><ArticleId IdType="pmc">PMC8760088</ArticleId><ArticleId IdType="pubmed">35069924</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, Molteni E, Modat M, Jorge Cardoso M, May A, Ganesh S, Davies R, Nguyen LH, Drew DA, Astley CM, Joshi AD, Merino J, Tsereteli N, Fall T, Gomez MF, Duncan EL, Menni C, Williams FMK, Franks PW, Chan AT, Wolf J, Ourselin S, Spector T, Steves CJ. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad MS, Shaik RA, Ahmad RK, Yusuf M, Khan M, Almutairi AB, Alghuyaythat WKZ, Almutairi SB. "LONG COVID": an insight. Eur Rev Med Pharmacol Sci. 2021;25(17):5561&#x2013;5577.</Citation><ArticleIdList><ArticleId IdType="pubmed">34533807</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E, Alpuente A, Torres-Ferrus M, Pozo-Rosich P. Toward a better understanding of persistent headache after mild COVID-19: three migraine-like yet distinct scenarios. Headache. 2021;61(8):1277&#x2013;1280. doi: 10.1111/head.14197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14197</ArticleId><ArticleId IdType="pmc">PMC8444902</ArticleId><ArticleId IdType="pubmed">34363619</ArticleId></ArticleIdList></Reference><Reference><Citation>Planchuelo-G&#xf3;mez &#xc1;, Trigo J, de Luis-Garc&#xed;a R, Guerrero &#xc1;L, Porta-Etessam J, Garc&#xed;a-Azor&#xed;n D&#xa0;(2020) Deep Phenotyping of Headache in Hospitalized COVID-19 Patients via Principal Component Analysis. Front Neurol 11:583870. 10.3389/fneur.2020.583870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773780</ArticleId><ArticleId IdType="pubmed">33391152</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolay H, G&#xfc;l A, Baykan B. COVID-19 is a real headache! Headache. 2020;60(7):1415&#x2013;1421. doi: 10.1111/head.13856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13856</ArticleId><ArticleId IdType="pmc">PMC7272895</ArticleId><ArticleId IdType="pubmed">32412101</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana M, Khaliq F, Zecca C, Figuerola MDL, Sances G, Di Piero V, Petolicchio B, Alessiani M, Geppetti P, Lupi C, Benemei S, Iannacchero R, Maggioni F, Jurno ME, Odobescu S, Chiriac E, Marfil A, Brighina F, Barrientos Uribe N, P&#xe9;rez Lago C, Bordini C, Lucchese F, Maffey V, Nappi G, Sandrini G, Tassorelli C. Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohort. Eur J Neurol. 2020;27(3):536&#x2013;541. doi: 10.1111/ene.14098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14098</ArticleId><ArticleId IdType="pubmed">31574197</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Tafuri E, Tana M, Martelletti P, Negro A, Affaitati G, Fabrizio A, Costantini R, Mezzetti A, Giamberardino MA. New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? J Headache Pain. 2013;14(1):9. doi: 10.1186/1129-2377-14-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1129-2377-14-9</ArticleId><ArticleId IdType="pmc">PMC3620371</ArticleId><ArticleId IdType="pubmed">23565964</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Giamberardino MA, Cipollone F. microRNA profiling in atherosclerosis, diabetes, and migraine. Ann Med. 2017;49(2):93&#x2013;105. doi: 10.1080/07853890.2016.1226515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2016.1226515</ArticleId><ArticleId IdType="pubmed">27560467</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsikostas DD, Ashina M, Craven A, Diener HC, Goadsby PJ, Ferrari MD, Lampl C, Paemeleire K, Pascual J, Siva A, Olesen J, Osipova V, Martelletti P, EHF committee European Headache Federation consensus on technical investigation for primary headache disorders. J Headache Pain. 2015;17:5. doi: 10.1186/s10194-016-0596-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-016-0596-y</ArticleId><ArticleId IdType="pmc">PMC4747925</ArticleId><ArticleId IdType="pubmed">26857820</ArticleId></ArticleIdList></Reference><Reference><Citation>Rom&#xe1;n GC, Spencer PS, Reis J, Buguet A, Faris MEA, Katrak SM, L&#xe1;inez M, Medina MT, Meshram C, Mizusawa H, &#xd6;zt&#xfc;rk S, Wasay M, WFN Environmental Neurology Specialty Group The neurology of COVID-19 revisited: a proposal from the Environmental Neurology Specialty Group of the world federation of neurology to implement international neurological registries. J Neurol Sci. 2020;414:116884. doi: 10.1016/j.jns.2020.116884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116884</ArticleId><ArticleId IdType="pmc">PMC7204734</ArticleId><ArticleId IdType="pubmed">32464367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767&#x2013;783. doi: 10.1016/S1474-4422(20)30221-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E, Pozo-Rosich P. Headache as a symptom of COVID-19: narrative review of 1-year research. Curr Pain Headache Rep. 2021;25(11):73. doi: 10.1007/s11916-021-00987-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-021-00987-8</ArticleId><ArticleId IdType="pmc">PMC8583579</ArticleId><ArticleId IdType="pubmed">34766205</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendtsen L, Evers S, Linde M, Mitsikostas DD, Sandrini G, Schoenen J. EFNS guideline on the treatment of tension-type headache &#x2013; report of an EFNS task force. Eur J Neurol. 2010;17(11):1318&#x2013;1325. doi: 10.1111/j.1468-1331.2010.03070.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2010.03070.x</ArticleId><ArticleId IdType="pubmed">20482606</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash S, Shah ND. Post-infectious new daily persistent headache may respond to intravenous methylprednisolone. J Headache Pain. 2010;11(1):59&#x2013;66. doi: 10.1007/s10194-009-0171-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10194-009-0171-x</ArticleId><ArticleId IdType="pmc">PMC3452180</ArticleId><ArticleId IdType="pubmed">19936615</ArticleId></ArticleIdList></Reference><Reference><Citation>Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache. 2015;55(1):3&#x2013;20. doi: 10.1111/head.12499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.12499</ArticleId><ArticleId IdType="pubmed">25600718</ArticleId></ArticleIdList></Reference><Reference><Citation>Krymchantowski AV, Silva-N&#xe9;to RP, Jevoux C, Krymchantowski AG. Indomethacin for refractory COVID or post-COVID headache: a retrospective study. Acta Neurol Belg. 2022;122(2):465&#x2013;469. doi: 10.1007/s13760-021-01790-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-021-01790-3</ArticleId><ArticleId IdType="pmc">PMC8453033</ArticleId><ArticleId IdType="pubmed">34546559</ArticleId></ArticleIdList></Reference><Reference><Citation>The International Classification of Headache Disorders 3rd edition (beta version) Cephalalgia. 2013;33(9):629&#x2013;808. doi: 10.1177/0333102413485658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102413485658</ArticleId><ArticleId IdType="pubmed">23771276</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali A, Kriegler J, Tepper S, Vij B. New daily persistent headache and OnabotulinumtoxinA therapy. Clin Neuropharmacol. 2019;42(1):1&#x2013;3. doi: 10.1097/WNF.0000000000000313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNF.0000000000000313</ArticleId><ArticleId IdType="pubmed">30499777</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelfand AA, Reider AC, Goadsby PJ. Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders. Pediatr Neurol. 2014;50(2):135&#x2013;139. doi: 10.1016/j.pediatrneurol.2013.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2013.09.008</ArticleId><ArticleId IdType="pmc">PMC3903978</ArticleId><ArticleId IdType="pubmed">24268688</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubio-Beltran E, Labastida-Ramirez A, Villalon CM, MaassenVanDenBrink A. Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy? Pharmacol Ther. 2018;186:88&#x2013;97. doi: 10.1016/j.pharmthera.2018.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2018.01.005</ArticleId><ArticleId IdType="pubmed">29352859</ArticleId></ArticleIdList></Reference><Reference><Citation>Deen M, Correnti E, Kamm K, Kelderman T, Papetti L, Rubio-Beltran E, et al. Blocking CGRP in migraine patients - a review of pros and cons. J Headache Pain. 2017;18(1):96. doi: 10.1186/s10194-017-0807-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-017-0807-1</ArticleId><ArticleId IdType="pmc">PMC5612904</ArticleId><ArticleId IdType="pubmed">28948500</ArticleId></ArticleIdList></Reference><Reference><Citation>Keith IM, Tjen-A-Looi S, Kraiczi H, Ekman R. Three-week neonatal hypoxia reduces blood CGRP and causes persistent pulmonary hypertension in rats. Am J Physiol Heart Circ Physiol. 2000;279(4):H1571&#x2013;H1578. doi: 10.1152/ajpheart.2000.279.4.H1571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.2000.279.4.H1571</ArticleId><ArticleId IdType="pubmed">11009443</ArticleId></ArticleIdList></Reference><Reference><Citation>Chippa V, Aleem A, Anjum F. Post acute coronavirus (COVID-19) syndrome. Treasure Island: StatPearls Publishing Copyright &#xa9; 2022, StatPearls Publishing LLC; 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">34033370</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer KP, Steele AK, Soper MK, Branton JD, Lusby ML, Kalema AG, et al. Physical therapy management of an individual with post-COVID syndrome: a case report. Phys Ther. 2021;101(6):pzab098. doi: 10.1093/ptj/pzab098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzab098</ArticleId><ArticleId IdType="pmc">PMC7989151</ArticleId><ArticleId IdType="pubmed">33735380</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis. 2021;8:20499361211009385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Probyn K, Bowers H, Mistry D, Caldwell F, Underwood M, Patel S, et al. Non-pharmacological self-management for people living with migraine or tension-type headache: a systematic review including analysis of intervention components. BMJ Open. 2017;7(8):e016670. doi: 10.1136/bmjopen-2017-016670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-016670</ArticleId><ArticleId IdType="pmc">PMC5629643</ArticleId><ArticleId IdType="pubmed">28801425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingstone T, Taylor AK, O'Donnell CA, Atherton H, Blane DN, Chew-Graham CA. Finding the 'right' GP: a qualitative study of the experiences of people with long-COVID. BJGP Open. 2020;4(5):bjgpopen20X101143. doi: 10.3399/bjgpopen20X101143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen20X101143</ArticleId><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Chappuis F, Courvoisier DS, Guessous I. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med. 2021;174(9):1252&#x2013;1260. doi: 10.7326/M21-0878.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-0878</ArticleId><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou MI, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas GP, et al. Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022;13:20406223221076890. doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker AM, Brigham E, Connolly B, McPeake J, Agranovich AV, Kenes MT, et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med. 2021;9(11):1328&#x2013;1341. doi: 10.1016/S2213-2600(21)00385-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00385-4</ArticleId><ArticleId IdType="pmc">PMC8525917</ArticleId><ArticleId IdType="pubmed">34678213</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Membrilla JA, Caronna E, Trigo-L&#xf3;pez J, et al. Persistent headache after COVID-19: Pathophysioloy, clinic and treatment. Neurol Perspect. 2021;1:S31&#x2013;S36. doi: 10.1016/j.neurop.2021.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurop.2021.10.003</ArticleId><ArticleId IdType="pmc">PMC8669731</ArticleId><ArticleId IdType="pubmed">38620971</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Rozen TD. The clinical characteristics of new daily persistent headache. Cephalalgia Int J Headache. 2002;22:66&#x2013;69. doi: 10.1046/j.1468-2982.2002.00326.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1468-2982.2002.00326.x</ArticleId><ArticleId IdType="pubmed">11993616</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas S, Hoffman JM, Bell KR, Dikmen S. A prospective study of prevalence and characterization of headache following mild traumatic brain injury. Cephalalgia. 2014;34(2):93&#x2013;102. doi: 10.1177/0333102413499645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102413499645</ArticleId><ArticleId IdType="pubmed">23921798</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>